During the corresponding time, Surrozen Inc recorded a revenue increase by 408.65 % year on year, sequentially revenue fell by 0 %. While revenue at the Surrozen Inc 's corporate clients
Surrozen Inc's Comment on Sales, Marketing and Customers
The company serves customers in the healthcare sector, including pharmaceutical manufacturers, prescribers, purchasers, and formulary managers. Its marketing, sales, and distribution activities are regulated by federal, state, and local authorities, including the FDA, CMS, HHS, and DOJ. The company operates in markets such as federal healthcare programs like Medicare and Medicaid, and must comply with laws including the federal Anti-Kickback Statute and the False Claims Act, which regulate interactions and financial arrangements with customers to prevent fraud and abuse.
In an exciting development for the field of respiratory diseases, Surrozen Inc. and TCGFB, Inc. have announced a strategic research collaboration aimed at developing transformative therapies for idiopathic pulmonary fibrosis (IPF). This partnership is poised to harness the power of TGF- antibodies, a promising avenue in the fight against this debilitating disease.Idiopathic pulmonary fibrosis is a progressive lung condition characterized by scar tissue formation that severely impairs the patient’s ability to breathe. While the etiology of IPF remains unknown, its impact on patients is significant, often leading to a decline in quality of life and prognosis. With limited therapeutic options currently availa...
Enhancing Wnt Signaling: Surrozen s SWEETS Platform Shows Potential in Groundbreaking Study In a recent publication in eLife, Surrozen, a biotechnology company, has unveiled its proprietary SWEETS (Selective Wnt Enhancer Evolved from Targeted Secretion) platform. This innovative technology demonstrates the potential to revolutionize targeted protein degradation, specifically to enhance Wnt signaling. This article explores the key findings of the study, evaluates the SWEETS platform, and assesses its potential impact on Surrozen and the larger biomedical field. SWEETS Platform: A Novel Approach to Protein DegradationThe SWEETS platform represents a breakthrough in targeted protein degradation technology. Unl...
Alcohol-Associated Hepatitis (AAH) is a life-threatening condition affecting individuals who consume excessive amounts of alcohol. It is characterized by inflammation and damage to the liver, leading to liver failure in severe cases. Currently, there is a pressing need for novel and effective treatments to address this condition. In this article, we will delve into recent advancements in the development of SZN-043 by Surrozen, a potential breakthrough therapy for patients suffering from severe AAH.Phase 1b Clinical Trial:Surrozen, a leading biotechnology company, has recently commenced the dosing of the first patient in a Phase 1b clinical trial evaluating the safety and efficacy of SZN-043. This trial marks...
Surrozen Inc’s Comment on Sales, Marketing and Customers
The company serves customers in the healthcare sector, including pharmaceutical manufacturers, prescribers, purchasers, and formulary managers. Its marketing, sales, and distribution activities are regulated by federal, state, and local authorities, including the FDA, CMS, HHS, and DOJ. The company operates in markets such as federal healthcare programs like Medicare and Medicaid, and must comply with laws including the federal Anti-Kickback Statute and the False Claims Act, which regulate interactions and financial arrangements with customers to prevent fraud and abuse.
Sources:
Surrozen Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Surrozen Inc’s corporate clients.
For your research, we’ve provided 9 tables on Surrozen Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
200 %